RLX Technology Inc. (RLX) Earnings Call Transcript & Summary

May 20, 2026

New York Stock Exchange US Consumer Staples Tobacco earnings 29 min

What were the key takeaways from RLX Technology Inc.'s May 20, 2026 earnings call?

In the first quarter of 2026, RLX Technology Inc. reported net revenues of RMB 1.59 billion, reflecting a remarkable 96.2% year-over-year increase and a 38.9% quarter-over-quarter rise. This strong performance was largely driven by robust international operations and the integration of a European acquisition. Management emphasized their commitment to innovation and compliance, signaling confidence in sustaining growth despite evolving regulatory landscapes. The company maintained a strong balance sheet, which positions it well for future expansion, particularly in Europe and Asia.

What topics did RLX Technology Inc. cover?

  • Revenue Growth Acceleration: RLX Technology achieved net revenues of RMB 1.59 billion, marking a 96.2% increase year-over-year and a 38.9% increase quarter-over-quarter. Management noted, "Our international business remained our key growth driver, accounting for over 70% of total net revenues for several consecutive quarters."
  • Margin Expansion: Gross margin improved to 31.8%, up from 28.6% in the same period last year, driven by a favorable product mix and supply chain optimization. Operating margin also expanded significantly, with non-GAAP operating margin reaching 19.6%, compared to 13.3% last year.
  • Regulatory Landscape Impact: Management highlighted the U.K.'s generational smoking ban as a structural tailwind for their business, stating, "This effectively positioned e-vapor as the only legal nicotine consumption channel for future generations..." This regulatory change is expected to enhance market share for compliant brands.
  • European Expansion Strategy: RLX is pursuing a dual engine strategy in Europe, focusing on both strategic M&A and organic growth. Management stated, "We are not seeking rapid entry, but rather building a durable presence with care and discipline," indicating a cautious yet optimistic approach.
  • Operational Efficiency: The company reported strong operational metrics, with accounts receivable turnover days at 15 and inventory turnover days at 32. This efficiency supports their growth strategy and enhances financial flexibility.

What were RLX Technology Inc.'s May 20, 2026 results?

  • Net Revenue: RMB 1.59 billion (up 96.2% YoY, +38.9% QoQ)
  • Gross Margin: 31.8% (up from 28.6% YoY)
  • Non-GAAP Operating Margin: 19.6% (up from 13.3% YoY)
  • Non-GAAP Income from Operations: RMB 310.3 million (up 187.9% YoY)
  • Non-GAAP Net Income: RMB 357.3 million (up 41.4% YoY)
  • Total Financial Assets: RMB 14.53 billion (down from RMB 15.73 billion QoQ)

RLX Technology's strong Q1 results and strategic focus on international expansion position it well for future growth. The favorable regulatory environment in the U.K. and improved operational efficiencies are key catalysts. However, investors should monitor regulatory developments in both the U.S. and China as potential risks.

Earnings Call Speaker Segments

Sam Tsang

executive
#1

Thank you very much. Hello, everyone, and welcome to RLX Technologies' First Quarter 2026 Earnings Conference Call, which we expect to run for roughly 40 minutes. The company's financial and operational results were released earlier today through PR Newswire services and can now be found online. You can also access the earnings press release on our IR website, ir.relxtech.com. With us on today's call are Ms. Kate Wang, our Chief Executive Officer; Mr. Chao Lu, our Chief Financial Officer; and Sam Tsang, Head of Capital Markets. Before we continue, please note that today's discussions will contain forward-looking statements made under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements generally include terms such as may, will, expect, anticipate, aim, estimate, intend, plan, believe, potential, continue, or similar expressions. Forward-looking statements involve inherent risks and uncertainties. Numerous business risks and uncertainties could influence how accurate these statements prove to be, leading actual results to differ materially from what was projected or anticipated. Many of those factors lie beyond our control. The company, its affiliate, advisers, and representatives undertake no obligation to update this forward-looking information, except as required under applicable law. Please note that RLX Technology's earnings press release and this conference call include discussions of unaudited GAAP financial measures as well as unaudited non-GAAP financial measures. RLX' press release includes a reconciliation of the unaudited non-GAAP measures to the unaudited GAAP measures. For today's call, management will use English as the primary language; simultaneous interpretation will be provided on the Chinese line. Please note that the Chinese line is listen-only, and the Chinese interpretation is provided for convenience only. If any discrepancy occurs, the management statements in the original language will prevail. I will now turn the call over to Ms. Kate Wang. Please go ahead.

Wang Ying

executive
#2

Thanks, Sam — and I appreciate everyone taking the time to be on today's call. We've gotten off to a strong beginning in 2023, backed by a worldwide ecosystem that scales extremely well and by our capacity to seize opportunities as the market rises. Revenue growth came in solid, climbing 96.2% compared with a year earlier and 38.9% versus the prior quarter, as we keep speeding up our push abroad and make our global footprint deeper. Our overseas operations carried on their swift organic expansion, and in Mainland China our business showed both durability and steadiness. We went further in honing a user-first model by means of sharply localized tactics and by working with dependable regional commercial partners throughout the value chain, so that we secure a stronger product market. In addition, we brought our R&D, manufacturing, and commercial operation together into a state-of-the-art hub that goes by the name Nexus, which sharpens our core strengths and competitive advantage even more. Thanks to these efforts, plus our expanding operational nimbleness, we can move quickly in step with shifting market conditions and smoothly satisfy demand around the world, which reinforces our foothold in important international markets. Now let me take you through the latest business update in greater depth. Rules worldwide governing tobacco and smokeless substitutes keep changing. A clear illustration is the United Kingdom's Landmark Tobacco and Race Act, which formally turned into law in April 2026, mirroring a worldwide movement toward retiring combustibles while keeping regulated routes open for harm reduction substitutes. According to this law, no one born up to 2009 will ever be legally able to buy combustible cigarettes. Crucially, the prohibition covers only cigarettes and exams regulated harm reduction substitutes like V. What the U.K. is doing, in practice, is steadily removing the future buyer base for cigarettes even as it keeps the current regulatory structure for our category intact. In our view, this will prove to be an isolated case. Around the globe, public health gains are increasingly chased by limiting tobacco while supervising harm reduction products; for businesses such as IX Technology that have robust compliance skills, top-tier product quality, and a forward-leaning regulatory stance, this amounts to a favorable structural tailwind instead of a headwind. A properly regulated market pays off for scale, compliance, and innovation — all fields in which we are already the leader. As regulatory ambiguity fades, the competitive field should grow clearer, and our distinctive standing could become still more valuable. Turning to our growth abroad. Europe remains the foundation stone of our worldwide strategy, because its regulatory setting is ever more mature and demand for premium alternatives runs strong. The strategic investment we made in May 2025 in a European company has produced value reaching far past the financial, boosting our skill at steering through local market conditions. Having integrated successfully and gained operational experience, we now feel confident enough to weigh additional expansion throughout the continent. A dual engine strategy propels our European growth, giving strategic M&A and organic growth the same weight. Though we feel good about Europe's potential, we stay very choosy about strategic investments, putting long-term synergy ahead of instant scale. Our emphasis is on creating a solid base via excellence in products and operations, designing offerings suited to European consumer tastes and regulatory requirements, while also strengthening distribution alliances and growing our footprint in important retail channels. Simultaneously, we're establishing a reputation as a trusted premium brand that connects with local lifestyles and delivers innovation users can depend on, making sure our footprint is both significant and enduring. All in all, we see Europe as a market of high value and high barriers; we aren't aiming for quick entry, but instead carefully and methodically constructing a lasting presence. On the operations front, I'm happy to report that our integrated smart manufacturing site in Nexus is now completely up and running. This goes beyond a mere manufacturing enhancement. By broadening our own manufacturing abilities and capacity and uniting R&D, production, and commercial activities under a single roof, we can aim for intricate, high-precision quality benchmarks and long-range strategic goals. Our in-house manufacturing also acts as a closed-loop fortress for intellectual property. Our proprietary technologies will stay entirely under our control, providing an edge that's hard for rivals to copy. Moreover, this integrated center has substantially boosted our operational efficiency, allowing quicker decisions and a more nimble reaction to shifts in the global market. In summary, we keep merging regulatory know-how with international market insights to construct a more robust, more scalable worldwide platform. Given this context, we stay concentrated on fueling innovation and user-focused product creation while additionally bolstering our distribution and retail strengths and speeding up our growth in Europe and instinctively protecting and raising our top market share in Asia. Going forward, with a strategy centered on quality-driven growth and a firm dedication to innovation and compliance, we'll keep providing sustainable long-term value to our global stakeholders. I'll now pass the call to Chao for a thorough review of our financial outcomes.

Chao Lu

executive
#3

Thanks, Kate, and good morning, everybody. During the opening quarter of 2026, we posted robust top line performance, with net revenues hitting RMB 1.59 billion, which represents a 96.2% rise versus the prior-year period and a 38.9% gain sequentially. Momentum throughout our overseas operations, the boost from the European business we acquired, continued advancement in our Mainland China operations, plus a onetime effect stemming from shifts in China's export policy, were the main forces behind this substantial expansion. Our business outside China kept serving as the primary engine of growth, representing more than 70% of overall net revenues across multiple quarters in a row. By managing costs with discipline and achieving scale efficiency throughout our broad product portfolio, we structurally enhanced our margin profile. In the first quarter, gross margin climbed to 31.8%, compared with 28.6% during the equivalent period a year earlier, largely fueled by a more favorable product mix and continuous supply chain optimization. The operating leverage generated by revenue growth also converted into considerable profitability. This quarter, our non-GAAP operating margin rose to 19.6%, versus 13.3% in the equivalent period last year. Non-GAAP income from operations surged 187.9% year-over-year, reaching RMB 310.3 million. Non-GAAP net income for the quarter came to RMB 357.3 million, marking a 41.4% gain relative to RMB 252.7 million in the equivalent period a year ago; this highlights our capacity to turn top line momentum into sustained, high-quality earnings growth; we keep a highly resilient financial position. As of March 31, 2026, our total financial assets, encompassing cash, cash equivalents along with various deposits and investments, amounted to RMB 14.53 billion, roughly USD 2.1 billion. Although this marks a sequential decline from RMB 15.73 billion as of December 31, 2025, that shift chiefly mirrors our dedication to returning value to shareholders via dividend payments distributed during the quarter. Our operational efficiency likewise stays robust, underpinned by effective working capital management and a tightly controlled cash conversion cycle. During the first quarter, accounts and notes receivable turnover days stood at 15 days. Inventory turnover days came in at 32 days, and payable turnover days were 49 days; we moved into the rest of the year with a solid balance sheet, giving us the financial flexibility to carry out our next phase of growth, speed up our market penetration across Asia and Europe, and produce sustainable long-term value for our shareholders.

Ling Zhou

analyst
#4

Great quarter, congrats to the management team. There are 2 things I'd like to ask. First off, could you give us an update on how things are going with bringing the European invested company together with your U.K. market operations? Then my second one relates to the latest FDA rulings approving flavored vapes in the U.S. So, does the management team see any effect on Relax's global strategy, particularly regarding what it might mean for operating in the U.S.? And on the other side, how would management evaluate the loosening of e-cigarette regulations in China?

Sam Tsang

executive
#5

Thanks a lot, Tony, for those 2 questions. Starting with the first one, which concerns our European strategy as well as our U.K. market operations. Our method for integration focuses on aligning strategically instead of meddling with daily operations; it's a relationship built on synergy; the deep local know-how and market understanding our team from the acquired European companies contributes is something we place great value on. In our view, their grasp of the local situation plays a key role in sharpening our wider European strategy. And right now, their perspectives are actively shaping our strategic choices; on the other side, we give them the tools to grow by supplying needed capital resources along with global platform support; as an example, a new local warehouse facility was recently invested in by us to fix earlier capital constraints that had been holding back their growth; this infrastructure lets them scale operations considerably and boost distribution efficiency. Going forward, we plan to use our cash position to assist them in locking down additional downstream resources. Through combining our worldwide innovation strengths with their localized setup, we can gain market share with greater efficiency. On your second question regarding the FDA's recent decisions, at present we have no operations in the United States. We're looking at these developments through a wider industry lens. The latest FDA guidance points to a possible move toward a clearer enforcement approach that might benefit credible PMT applications coming from legitimate industry players. Though this may make product launch more foreseeable for the industry, we can't speculate about what future regulatory outcomes will be in that market. Turning to the China market, we back regulators in their fight against illegal products and welcome steps that encourage a healthier, more sustainable industry. When it comes to product innovation and brand equity, we stay fully ready to react to any regulatory shifts. Right now, our near-term strategic priority continues to be strengthening our footprint in Asia and Europe along with other established international regions, where the operational levers available to us are clear. — we direct resources toward markets where tangible growth can be driven today. Many thanks for your questions.

Lydia Ling

analyst
#6

Nice work on those numbers. I want to ask about what's happening in Europe for you. Over in the U.K., there's now a law in effect prohibiting smoking for anyone born after 2008 — what kind of effect does that have on your company? Would you say it will drive more growth in the vape segment? And how do you see Europe shaping up going forward? I believe you brought up a strategic focus as well. So what sort of growth projection do you have for Europe this year?

Sam Tsang

executive
#7

Thanks a lot for that, Lydia. From where we sit, the U.K.'s generational smoking prohibition marks a major step in the government's long-term commitment toward a smoke-free future. One thing worth highlighting: combustible cigarettes are what's covered by this ban, yet e-vapor remains purchasable at 18. So for the younger generations—those born after 2008—when they reach adulthood, e-vapor becomes the only legal way to get nicotine. That cements its role as the primary harm reduction choice. Beyond that, once you combine this prohibition with the vaping product duty arriving in October 2026 and the HMRC licensing scheme, entry barriers rise considerably. Our take is that this effectively clears noncompliant brands out of the market, which allows established compliance leaders such as Rx to reclaim and expand our share in the U.K. market, generating roughly $2.11 billion. Many thanks for your question.

Zhuonan Xu

analyst
#8

Could you share any updates regarding your European investment plans and the market approach for new categories such as oral pouch and HMB?

Sam Tsang

executive
#9

Thanks for asking that. Our strategy for Europe keeps to a dual engine model. The management team has moved its attention considerably toward European operations, and this quarter we managed to enter new regions and channels. We draw on a growing knowledge of the European consumer to sharpen our competitive position. On the M&A side, we are actively assessing opportunities with clear long-term strategies. That said, we stay very disciplined and cautious about valuations. Although plenty of potential opportunities exist, such projects carry inherent uncertainties. As a result, unannounced projects are not part of our recent guidance, and we will provide updates only once they materialize. As for the new categories you raised, in modern oral products we are steadily expanding production capacity and actively seeking new distribution channels. We hold strong confidence in how competitive our oral products are, and they are highly differentiated. Once our overseas manufacturing infrastructure is fully in place, we anticipate a significant uplift in sales volume. When it comes to HMV heated tobacco, we do possess the necessary technical results for this category, but our current assessment of market dynamics indicates the timing is not optimal for large-scale investment. So we have no immediate launch plan for this category. Our main focus stays on capturing more market share within the e-vapor sector, where we see the most immediate and substantial opportunities for growth. Thank you for your question.

Yun Guo

analyst
#10

I'd like to know whether removing China's export tax rebate is going to have an effect on what it costs the company to produce.

Sam Tsang

executive
#11

Thanks for asking that. Over the near term, the policy change we anticipated played a part in the big jump in our revenue for the first quarter, since the cancellation kicked in during April 2026; throughout that quarter, we saw partners further down the chain doing strategic positioning of inventory so they could soften possible price moves. That pull-forward dynamic has mostly played out by now, and what we witnessed was a fairly modest overall amount of that advance buying. Let me be clear on one point: organic demand from end users is barely touched by this policy shift. What it did was temporarily move around when channel orders were placed — given that the e-vapor value chain has several layers, the effect this tax change will actually have on what consumers ultimately pay at retail should be something we can handle. Where it becomes necessary, we'll put suitable cost pass-through mechanisms in place, and our view is that any consequence for our cost structure and margins over the long run will be very small. Thanks for your question.

Charlie Chen

analyst
#12

I'd appreciate it if management could share additional details regarding where things stand right now with your expansion abroad; and, additionally, did you launch in any additional countries during Q1?

Sam Tsang

executive
#13

Charlie, many thanks for asking that. During Q1 of the present year, we managed to launch in 2 markets situated in Southeast Asia and Europe. Our worldwide growth plan is moving forward nicely, consistent with the segmented strategy we follow, which reflects differing levels of maturity across markets. Throughout Asia, a region where we've built our position as the #1 brand, what we prioritize is capitalizing on our considerable brand equity and scale, treating them as a competitive moat. The top-of-mind brand awareness we enjoy with adult users across these areas lets us move into adjacent new markets quite efficiently and with consumer trust. Essentially, what we're doing is copying our established SaaS models while continuing to expand our distribution network further. When it comes to Europe, we're currently in an energetic stage of strategic exploration and adoption. Even though that landscape varies considerably, our confidence keeps growing as we sharpen our grasp of local consumer preferences along with the shifting regulatory framework. The way we operate there is more subtle, centered on providing customized, premium offerings and establishing deeply rooted partnerships with local stakeholders, so that long-term and compliance growth is assured. Thanks for your question.

Sam Tsang

executive
#14

We appreciate you being with us once more. Should anything else come to mind, you're welcome to reach out to the RH Technologies Investor Relations team — either by using the contact details listed on our website or by getting in touch with Piacente Financial Communications.

Operator

operator
#15

That brings today's presentation to a close, and we appreciate your joining us. You're welcome to hang up at this point.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete RLX Technology Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to RLX Technology Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in RLX Technology Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.